Amir S - Search Results

1

The cellular immune response to influenza vaccination is preserved in rheumatoid arthritis patients treated with rituximab.

Arad U, Tzadok S, Amir S, Mandelboim M, Mendelson E, Wigler I, Sarbagil-Maman H, Paran D, Caspi D, Elkayam O. Arad U, et al. Among authors: amir s. Vaccine. 2011 Feb 11;29(8):1643-8. doi: 10.1016/j.vaccine.2010.12.072. Epub 2011 Jan 4. Vaccine. 2011. PMID: 21211590

2

Efficacy and safety of vaccination against pandemic 2009 influenza A (H1N1) virus among patients with rheumatic diseases.

Elkayam O, Amir S, Mendelson E, Schwaber M, Grotto I, Wollman J, Arad U, Brill A, Paran D, Levartovsky D, Wigler I, Caspi D, Mandelboim M. Elkayam O, et al. Among authors: amir s. Arthritis Care Res (Hoboken). 2011 Jul;63(7):1062-7. doi: 10.1002/acr.20465. Arthritis Care Res (Hoboken). 2011. PMID: 21425247 Free article. Clinical Trial.

3

Galectin-3 is a sensor-regulator of toll-like receptor pathways in synovial fibroblasts.

Arad U, Madar-Balakirski N, Angel-Korman A, Amir S, Tzadok S, Segal O, Menachem A, Gold A, Elkayam O, Caspi D. Arad U, et al. Among authors: amir s. Cytokine. 2015 May;73(1):30-5. doi: 10.1016/j.cyto.2015.01.016. Epub 2015 Feb 14. Cytokine. 2015. PMID: 25689620

4

1alpha,25-dihydroxyvitamin D3 (Calcitriol) inhibits hypoxia-inducible factor-1/vascular endothelial growth factor pathway in human cancer cells.

Ben-Shoshan M, Amir S, Dang DT, Dang LH, Weisman Y, Mabjeesh NJ. Ben-Shoshan M, et al. Among authors: amir s. Mol Cancer Ther. 2007 Apr;6(4):1433-9. doi: 10.1158/1535-7163.MCT-06-0677. Mol Cancer Ther. 2007. PMID: 17431122

5

Detection of prostate specific transcripts in the peripheral blood during brachytherapy predicts postoperative PSA kinetics.

Mabjeesh NJ, Amir S, Stenger A, Chen J, Matzkin H. Mabjeesh NJ, et al. Among authors: amir s. Prostate. 2009 Aug 1;69(11):1235-44. doi: 10.1002/pros.20977. Prostate. 2009. PMID: 19434652

6

Hypoxia induces PTHrP gene transcription in human cancer cells through the HIF-2α.

Manisterski M, Golan M, Amir S, Weisman Y, Mabjeesh NJ. Manisterski M, et al. Among authors: amir s. Cell Cycle. 2010 Sep 15;9(18):3723-9. Epub 2010 Sep 7. Cell Cycle. 2010. PMID: 20890122

7

Targeted knockdown of SEPT9_v1 inhibits tumor growth and angiogenesis of human prostate cancer cells concomitant with disruption of hypoxia-inducible factor-1 pathway.

Amir S, Golan M, Mabjeesh NJ. Amir S, et al. Mol Cancer Res. 2010 May;8(5):643-52. doi: 10.1158/1541-7786.MCR-09-0497. Epub 2010 Apr 20. Mol Cancer Res. 2010. PMID: 20407014

8

SEPT9_v1 up-regulates hypoxia-inducible factor 1 by preventing its RACK1-mediated degradation.

Amir S, Wang R, Simons JW, Mabjeesh NJ. Amir S, et al. J Biol Chem. 2009 Apr 24;284(17):11142-51. doi: 10.1074/jbc.M808348200. Epub 2009 Feb 26. J Biol Chem. 2009. PMID: 19251694 Free PMC article.

9

Hypoxia-inducible factor (HIF) in human tumorigenesis.

Mabjeesh NJ, Amir S. Mabjeesh NJ, et al. Among authors: amir s. Histol Histopathol. 2007 May;22(5):559-72. doi: 10.14670/HH-22.559. Histol Histopathol. 2007. PMID: 17330811 Review.

10

SEPT9_V1 protein expression is associated with human cancer cell resistance to microtubule-disrupting agents.

Amir S, Mabjeesh NJ. Amir S, et al. Cancer Biol Ther. 2007 Dec;6(12):1926-31. doi: 10.4161/cbt.6.12.4971. Epub 2007 Sep 1. Cancer Biol Ther. 2007. PMID: 18075300 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

445 results

Search Page

Filters